Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 15.36% is 12% below its 5-year average of 17.52%, around the middle of its 5-year range (-21.72%–46.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.88% below its 12-month average of 19.42%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 15.36%.
RETURN ON EQUITY (ROE)
15.36%
RETURN ON EQUITY (ROE) AVG TTM
19.42%
RETURN ON EQUITY (ROE) AVG 3Y
22.78%
RETURN ON EQUITY (ROE) AVG 5Y
17.52%
RETURN ON EQUITY (ROE) AVG 10Y
-13.76%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.88%
CURRENT VS 3Y AVG
-32.55%
CURRENT VS 5Y AVG
-12.30%
CURRENT VS 10Y AVG
+211.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.92%
median of 594 covered companies
CURRENT VS SECTOR MEDIAN
+138.48%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$722.58M
Return on Equity (ROE)
15.36%
TTM Avg
19.42%
3Y Avg
22.78%
5Y Avg
17.52%
Market Cap
$723.20M
Return on Equity (ROE)
-25.03%
TTM Avg
-10.49%
3Y Avg
-5.87%
5Y Avg
-23.97%
Market Cap
$715.38M
Return on Equity (ROE)
-47.51%
TTM Avg
-32.80%
3Y Avg
-39.18%
5Y Avg
-31.37%
Market Cap
$725.41M
Return on Equity (ROE)
-22.36%
TTM Avg
-60.32%
3Y Avg
-42.71%
5Y Avg
-132.49%
Market Cap
$701.53M
Return on Equity (ROE)
-41.20%
TTM Avg
50554.28%
3Y Avg
25132.94%
5Y Avg
16622.35%
Market Cap
$740.17M
Return on Equity (ROE)
N/A
TTM Avg
-222.26%
3Y Avg
276.12%
5Y Avg
157.82%
Market Cap
$743.46M
Return on Equity (ROE)
-113.05%
TTM Avg
-95.98%
3Y Avg
-72.88%
5Y Avg
-73.85%
Market Cap
$691.42M
Return on Equity (ROE)
-108.93%
TTM Avg
-72.41%
3Y Avg
-64.95%
5Y Avg
-55.74%
Market Cap
$752.87M
Return on Equity (ROE)
-70.19%
TTM Avg
-78.37%
3Y Avg
-123.45%
5Y Avg
-79.18%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $722.58M | 15.36% | 19.42% | 22.78% | 17.52% |
| Cytek Biosciences, Inc. (CTKB)vs › | $723.20M | -25.03% | -10.49% | -5.87% | -23.97% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $715.38M | -47.51% | -32.80% | -39.18% | -31.37% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $725.41M | -22.36% | -60.32% | -42.71% | -132.49% |
| Anteris Technologies Global Corp. (AVR)vs › | $701.53M | -41.20% | 50554.28% | 25132.94% | 16622.35% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $740.17M | N/A | -222.26% | 276.12% | 157.82% |
| Faeth Therapeutics, Inc. (FTH)vs › | $743.46M | -113.05% | -95.98% | -72.88% | -73.85% |
| Annexon, Inc. (ANNX)vs › | $691.42M | -108.93% | -72.41% | -64.95% | -55.74% |
| Candel Therapeutics, Inc. (CADL)vs › | $752.87M | -70.19% | -78.37% | -123.45% | -79.18% |
| Helus Pharma Inc. (HELP)vs › | $685.23M | -75.79% | -55.51% | -59.06% | -60.41% |
ROE
15.4%
ROA
2.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 15.36% |
| 2026-03-31 | 23.99% |
| 2025-12-31 | 20.84% |
| 2025-09-30 | 21.27% |
| 2025-06-30 | 15.62% |
| 2025-03-31 | 18.72% |
| 2024-12-31 | 30.23% |
| 2024-09-30 | 37.82% |
| 2024-06-30 | 46.12% |
| 2024-03-31 | 41.99% |
| 2023-12-31 | 24.64% |
| 2023-09-30 | 5.04% |
| 2023-06-30 | -5.56% |
| 2023-03-31 | -16.33% |
| 2022-12-31 | -12.83% |
| 2022-09-30 | -21.72% |
| 2022-06-30 | -17.84% |
| 2022-03-31 | 21.82% |
| 2021-12-31 | 35.24% |
| 2021-09-30 | 41.22% |
| 2021-06-30 | 42.18% |
| 2021-03-31 | 24.68% |
| 2020-12-31 | 14.38% |
| 2020-09-30 | 10.19% |
| 2020-06-30 | 0.13% |
| 2020-03-31 | -8.91% |
| 2019-12-31 | -25.99% |
| 2019-09-30 | -13.57% |
| 2019-06-30 | -25.43% |
| 2019-03-31 | -34.95% |
| 2018-12-31 | -42.72% |
| 2018-09-30 | -92.71% |
| 2018-06-30 | -75.44% |
| 2018-03-31 | -77.56% |
| 2017-12-31 | -71.93% |
| 2017-09-30 | -88.32% |
| 2017-06-30 | -102.82% |
| 2017-03-31 | -88.84% |
| 2016-12-31 | -69.81% |
| 2016-09-30 | -102.44% |
| 2016-06-30 | -59.86% |
| 2016-03-31 | -32.21% |
| 2015-12-31 | -32.04% |
| 2015-09-30 | -22.66% |
| 2015-06-30 | -17.96% |
| 2015-03-31 | -51.78% |
